Patricia A. Bednarik, MS, CCC-SLP
The incidence of documented cognitive abnormalities (per neuropsychological assessment) is 40%-65% in people with Multiple Sclerosis (MS). Cognitive abnormalities in MS have been shown to correlate with decreased quality of life. What remains less understood is the extent to which standardized testing protocols reflect cognitive functioning in day-to-day living. Several factors, such as the testing environment and limitations of traditional tests as well as aggravating co-morbid and environmental conditions may bear some responsibility for this enigma.
